Dynamic rheology in combination with Fourier transform infrared spectroscopy (FTIR) is used to examine the gelation kinetics, mechanism, and gel point of novel thiol−acrylate systems containing varying concentrations of an in situ catalyst. Gelation, as evidenced from the gel time determined using the Winter− Chambon criterion, is found to occur more quickly with increasing catalyst concentration up until a critical catalyst concentration of 22 mol %, whereupon the gel time lengthens. Such a minimum in gel time may be attributed to changes in the number of available reaction sites and percentage conversion required for gelation. Chemical conversions at the gel point measured for representative samples are consistent with theoretical values calculated using Flory−Stockmayer's statistical approach, confirming our hypothesis. Relaxation exponents of 0.97 and fractal dimensions of 1.3 are calculated for all samples, consistent with coarse-grained discontinuous molecular dynamics (DMD) simulations. The elevated value of n may be due to the low molecular weight prepolymer. The relaxation exponent and fractal dimensions are invariable over all systems studied, suggesting the cross-linking mechanism remains unaffected by changes in catalyst concentration, allowing the gel time to be tailored by simply modulating the catalyst concentration.
In situ tertiary amine-catalyzed thiol-acrylate chemistry was employed to produce hydrophilic microfluidic devices via a soft lithography process. The process involved the Michael addition of a secondary amine to a multifunctional acrylate producing a nonvolatile in situ tertiary amine catalyst/comonomer molecule. The Michael addition of a multifunctional thiol to a multifunctional acrylate was facilitated by the catalytic activity of the in situ catalyst/comonomer. These cost-efficient thiol-acrylate devices were prepared at room temperature, rapidly, and with little equipment. The thiol-acrylate thermoset materials were more natively hydrophilic than the normally employed poly(dimethylsiloxane) (PDMS) thermoset material, and the surface energies were stable compared to PDMS. Because the final chip was self-adhered via a simple chemical process utilizing the same chemistry, and it was naturally hydrophilic, there was no need for expensive instrumentation or complicated methods to "activate" the surface. There was also no need for postprocessing removal of the catalyst as it was incorporated into the polymer network. These bottom-up devices were fabricated to completion proving their validity as microfluidic devices, and the materials were manipulated and characterized via various analyses illustrating the potential diversity and tunability of the devices.
Bone tissue engineering approaches using polymer/ceramic composites show promise as effective biocompatible, absorbable, and osteoinductive materials. A novel class of in situ polymerizing thiol-acrylate based copolymers synthesized via an amine-catalyzed Michael addition was studied for its potential to be used in bone defect repair. Both pentaerythritol triacrylate-co-trimethylolpropane tris(3-mercaptopropionate) (PETA-co-TMPTMP) and PETA-co-TMPTMP with hydroxyapatite (HA) composites were fabricated in solid cast and foamed forms. These materials were characterized chemically and mechanically followed by an in vitro evaluation of the biocompatibility and chemical stability in conjunction with human adipose-derived mesenchymal pluripotent stem cells (hASC). The solid PETA-co-TMPTMP with and without HA exhibited compressive strength in the range of 7-20 MPa, while the cytotoxicity and biocompatibility results demonstrate higher metabolic activity of hASC on PETA-co-TMPTMP than on a polycaprolactone control. Scanning electron microscope imaging of hASC show expected spindle shaped morphology when adhered to copolymer. Micro-CT analysis indicates open cell interconnected pores. Foamed PETA-co-TMPTMP HA composite shows promise as an alternative to FDA-approved biopolymers for bone tissue engineering applications.
A thiol-acrylate-based copolymer synthesized via an amine-catalyzed Michael addition was studied in vitro and in vivo to assess its potential as an in situ polymerizing graft or augment in bone defect repair. The blends of hydroxyapatite (HA) with pentaerythritol triacrylate-co-trimethylolpropane (PETA), cast as solids or gas foamed as porous scaffolds, were evaluated in an effort to create a biodegradable osteogenic material for use as a bone-void-filling augment. Osteogenesis experiments were conducted with human adipose-derived mesenchymal stromal cells (hASCs) to determine the ability of the material to serve as an osteoinductive substrate. Poly(ɛ-caprolactone) (PCL) composites PCL:HA (80:20) (wt/wt%) served as the control scaffold, while the experimental scaffolds included PETA:HA (100:0), (85:15), (80:20), and (75:25) composites (wt/wt%). The results indicate that PETA:HA (80:20) foam composites had higher mechanical strength than the corresponding porous PCL:HA (80:20) scaffolds made by thermo-precipitation method, and in the case of foamed composites, increasing HA content directly correlated with increased yield strength. For cytotoxicity and osteogenesis experiments, hASCs cultured for 21 days on PETA:HA scaffolds in stromal medium displayed the greatest number of live cells compared with PCL:HA composites. Moreover, hASCs cultured on foamed PETA:HA (80:20) scaffolds resulted in the greatest mineralization, increased alkaline phosphatase (ALP) expression, and the highest osteocalcin (OCN) expression after 21 days. Overall, the PETA:HA (80:20) and PETA:HA (85:15) scaffolds, with 66.38% and 72.02% porosity, respectively, had higher mechanical strength and cytocompatibility compared with the PCL:HA control. The results of the 6-week in vivo biocompatibility study using a posterior lumbar spinal fusion model demonstrate that PETA:HA can be foamed in vivo without serious adverse effects at the surgical site. Additionally, it was demonstrated that cells migrate into the interconnected pore volume and are found within centers of ossification.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.